Palisade Bio Inc. (PALI) Misses Q3 EPS by 232c

Palisade Bio Inc. (NASDAQ: PALI) reported Q3 EPS of ($2.32).

For earnings history and earnings-related data on Palisade Bio Inc. (PALI) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Morgan Stanley cuts China property forecasts on deeper price drops
• Shein targets $26-27 billion valuation in Hong Kong IPO - report